Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019

QR Code

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Marco Rossato, Angelo Di Vincenzo
Format:	article
Langue:	EN
Publié:	Radcliffe Medical Media 2020
Sujets:	Diseases of the circulatory (Cardiovascular) system RC666-701
Accès en ligne:	https://doaj.org/article/3fae216483b24c21bb8e521c10d63e6f
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
par: Maki Komiyama, et autres
Publié: (2020)

The impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction
par: Osama A. Amin, et autres
Publié: (2021)

Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy
par: Bin Tu, et autres
Publié: (2021)

Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic
par: Maki Komiyama, et autres
Publié: (2020)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
par: Eliecer Coto, et autres
Publié: (2021)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
par: Zhang C, et autres
Publié: (2021)

Effects of adding tripterygium glycosides to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy
par: Jin-Ying Fang, et autres
Publié: (2020)

Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers on insulin sensitivity in hypertensive patients: A meta-analysis of randomized controlled trials.
par: Jia Yao, et autres
Publié: (2021)

Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019
par: Meng-Yuan Liu, et autres
Publié: (2020)

Association of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers with risk of mortality, severity or SARS-CoV-2 test positivity in COVID-19 patients: meta-analysis
par: Mohitosh Biswas, et autres
Publié: (2021)

Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction
par: Giuseppe MC Rosano, et autres
Publié: (2019)

Use of Renin–Angiotensin–Aldosterone System Inhibitors in Older Patients with Heart Failure and Reduced Ejection Fraction
par: Davide Stolfo, et autres
Publié: (2019)

Comparative efficacy and predictive value of fixed combination of amlodipine and angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in patients with coronary heart disease, post-infarction cardiosclerosis and hypertension
par: M. M. Dolzhenko, et autres
Publié: (2021)

Effect of Angiotensin Receptor Blocker and Angiotensin Converting Enzyme Inhibitor on Kidney Function and Blood Potassium Level in Indonesian Type 2 Diabetes Mellitus with Hypertension: A Three-Month Cohort Study
par: Puspita FM, et autres
Publié: (2021)

Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia
par: Selçuk Görmez, et autres
Publié: (2021)

The role of doctors in smoking cessation: evidence from the Cochrane Library
par: Tim Lancaster
Publié: (2021)

A systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence
par: Gonjin Song, et autres
Publié: (2021)

New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.
par: Miklós Fagyas, et autres
Publié: (2014)

Safety and effectiveness of angiotensin receptor-neprilysin inhibitors (ARNI) in patients with heart failure with preserved ejection fraction (HFPEF) – ‘ARNI-preserved’ study
par: Pankaj Jariwala, et autres
Publié: (2021)

New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human.
par: Miklós Fagyas, et autres
Publié: (2014)

Coronavirus Disease 2019 and Cardiac Arrhythmias
par: Antoni Martínez-Rubio, et autres
Publié: (2020)

Electrophysiology in the Era of Coronavirus Disease 2019
Publié: (2020)

Coronavirus disease 2019 and flight safety
par: Sevgi Özcan
Publié: (2021)

Angiotensin-converting enzyme polymorphisms AND Alzheimer's disease susceptibility: An updated meta-analysis.
par: Xiao-Yu Xin, et autres
Publié: (2021)

Increased urinary angiotensin-converting enzyme 2 in renal transplant patients with diabetes.
par: Fengxia Xiao, et autres
Publié: (2012)

Angiotensin converting enzyme 2 is a novel target of the γ-secretase complex
par: Alberto Bartolomé, et autres
Publié: (2021)

Coronavirus Disease 2019: Where are we and Where are we Going? Intersections Between Coronavirus Disease 2019 and the Heart
par: Emilia D’Elia, et autres
Publié: (2020)

Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)
par: Berkay Ekici, et autres
Publié: (2021)

Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
par: Oghenemega Okoloko, et autres
Publié: (2021)

Treatment of Coronavirus Disease 2019: Shooting in the Dark
par: Juan Tamargo
Publié: (2020)

Mechanisms of Myocardial Injury in Coronavirus Disease 2019
par: Aniket S Rali, et autres
Publié: (2020)

Stretching the limits of antiarrhythmic drug therapy: The promise of small-conductance calcium-activated potassium channel blockers
par: Jordi Heijman, et autres
Publié: (2021)

Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea
par: Seung-Hwa Lee, et autres
Publié: (2021)

Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism and ACE inhibitor-related cough: a meta-analysis.
par: Ya-Feng Li, et autres
Publié: (2012)

Effect of telmisartan, angiotensin‐converting enzyme inhibition, or both, on proteinuria and blood pressure in dogs
par: Brittany L. Fowler, et autres
Publié: (2021)

The Chemical Compounds of Flacourtia rukam Leaves and Their Inhibition of Angiotensin-converting Enzyme (ACE) Activity
par: Muharni Muharni, et autres
Publié: (2021)

Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management
par: Mahmoud Abdelnabi, et autres
Publié: (2020)

Myocardial and Microvascular Injury Due to Coronavirus Disease 2019
par: Rocco A Montone, et autres
Publié: (2020)

Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
par: Maki Komiyama, et autres
Publié: (2021)

Acute myocarditis after coronavirus disease 2019 vaccination
par: Beuy Joob, et autres
Publié: (2021)